Iran reveals COVID-19 data for November 27| MENAFN.COM

Friday, 21 January 2022 09:21 GMT

Iran reveals COVID-19 data for November 27


(MENAFN- AzerNews) By Trend

As many as 3,045 people have been infected with the coronavirus (COVID-19) in the past 24 hours in Iran, reads the statement of the Ministry of Health and Medical Education of Iran, Trend reports.

In addition, 87 people have died from the coronavirus over the past day.

At the same time, the condition of 3,356 people remains critical.

So far, more than 38.4 million tests have been conducted in Iran for the diagnosis of coronavirus.

In total, about 105 million doses of vaccines have been used in Iran so far. About 57.3 million doses have been used on the first stage, 46.3 million doses - on the second stage, and 948,000 – on the third stage.

Iran continues to monitor the coronavirus situation in the country. According to recent reports from Iranian officials, over 6.1 million people have been infected, and 129,549 people have already died.

Meanwhile, over 5.85 million people have reportedly recovered from the disease.

The country continues to apply strict measures to contain further spread. Reportedly, the disease was brought to Iran by a businessman from Iran's Qom city, who went on a business trip to China, despite official warnings. The man died later from the disease.

The Islamic Republic only announced its first infections and deaths from the coronavirus on Feb. 19.

The outbreak in the Chinese city of Wuhan - which is an international transport hub - began at a fish market in late December 2019.

The World Health Organization (WHO) on March 11 declared COVID-19 a pandemic. Some sources claim the coronavirus outbreak started as early as November 2019.

---

Follow us on Twitter @AzerNewsAz

MENAFN27112021000195011045ID1103260251


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.